Global Clinical Trial Manager
Robert is responsible for the operational activities and implementation of clinical studies with arfolitixorin (Modufolin®) within Osteosarcom. In addition, Robert is responsible for research-initiated studies with arfolitixorin (Modufolin®). Robert has an M.Sc. in analytical chemistry from the University of Gothenburg. His professional experience includes more than 17 years of clinical research experience from both the pharmaceutical and medical technology industry.
Robert has worked at Isofol Medical AB since October 2017.
Phone: 46+ (0) 705 697 838